Related Experiment Video
Updated: Jun 19, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Medulloblastoma incidence has not changed over time: a CBTRUS study
Sonia Partap1, Emily K Curran, Jennifer M Propp
1Department of Neurology, Stanford University, Palo Alto, CA 94305-5826, USA. spartap@stanford.edu
Journal of Pediatric Hematology/Oncology
|November 6, 2009
Summary
Medulloblastoma (MB) incidence remained stable over two decades. However, combining medulloblastoma and primitive neuroectodermal tumors (PNET) showed an increased incidence, likely due to improved classification.
Area of Science:
- Neuro-oncology
- Epidemiology
- Cancer Research
Background:
- Previous studies on medulloblastoma (MB) incidence reported conflicting results.
- Potential reasons for discrepancies include small sample sizes and misclassification of MB with primitive neuroectodermal tumors (PNET).
Purpose of the Study:
- To accurately determine the incidence of medulloblastoma (MB) and primitive neuroectodermal tumors (PNET).
- To analyze trends in MB and PNET incidence from 1985 to 2002.
Main Methods:
- Utilized data from the Central Brain Tumor Registry of the United States (CBTRUS).
- Employed strict histologic and site codes for accurate case classification.
- Analyzed population-based cancer registry data spanning 1985–2002.
Main Results:
- No statistically significant change in medulloblastoma (MB) incidence was observed over the 20-year period.
- An increase in the combined incidence of medulloblastoma (MB) and primitive neuroectodermal tumors (PNET) was detected.
Conclusions:
- Medulloblastoma (MB) incidence has remained stable, suggesting no overall increase in this specific tumor type.
- The observed rise in combined MB and PNET incidence may reflect improved diagnostic criteria and reduced misclassification over time.
Related Concept Videos
01:08Prevalence and Incidence
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...